-+ 0.00%
-+ 0.00%
-+ 0.00%

Alamar Biosciences Raises FY2026 Sales Guidance from $116.000M-$120.000M to $121.000M-$123.000M vs $118.632M Est

Benzinga·11/03/2026 21:13:50
Listen to the news
Alamar Biosciences (NASDAQ:ALMR) raises FY2026 sales outlook from $116.000 million-$120.000 million to $121.000 million-$123.000 million vs $118.632 million estimate.